๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Design, synthesis and biological evaluation of succinimide derivatives as potential mechanism-based inhibitors of human leukocyte elastase, cathepsin G and proteinase 3

โœ Scribed by William C. Groutas; Michael J. Brubaker; Lee S. Chong; Radhika Venkataraman; He Huang; Jeffrey B. Epp; Rongze Kuang; John R. Hoidal


Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
572 KB
Volume
3
Category
Article
ISSN
0968-0896

No coin nor oath required. For personal study only.

โœฆ Synopsis


Structure-activity relationship study and in vitro biochemical studies with human leukocyte elastase, cathepsin G and proteinase 3 were conducted using a series of succinimide derivatives.


๐Ÿ“œ SIMILAR VOLUMES


The Gabriel-Colman rearrangement in biol
โœ William C. Groutas; Lee S. Chong; Radhika Venkataraman; Jeffrey B. Epp; Rongze K ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 574 KB

Almtraet--The results of a structure-activity relationship study focusing on the interaction of a series of phthalimide and saccharin derivatives with leukocyte elastase, cathepsin G and proteinase 3 are described. The phthalimide derivatives were found to be inactive while some of the saccharin der

Design, synthesis, and in vitro inhibito
โœ William C. Groutas; Jeffrey B. Epp; Radhika Venkataraman; Rongze Kuang; Tien My ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 604 KB

The inhibitory activity toward human leukocyte elastase (HLE), cathepsin G (Cat G), and proteinase 3 (PR 3) of a series of saccharin derivatives having a sulfinate leaving group was investigated. The results of this study revealed that (a) inhibitory activity is dependent on the nature and pKa of th

Pharmacophore-based design, synthesis, a
โœ Hongliang Wang; Junhai Xiao; Dapeng Gao; Xian Zhang; Hui Yan; Zehui Gong; Tinmin ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 512 KB

A series of chloro-pyridazine piperazines were developed based on the structure of human rhinovirus (HRV) capsid-binding inhibitors with proven activity using a pharmacophore model. A preliminary evaluation demonstrated potent activity against HRV-3 with low cytotoxicity. A docking analysis indicate